TY  - JOUR
AU  - Gomez-Garcia, Francisco
AU  - Gomez-Arias, Pedro Jesus
AU  - Hernandez, Jorge
AU  - Montilla, Ana Maria
AU  - Gay-Mimbrera, Jesus
AU  - Aguilar-Luque, Macarena
AU  - Viguera-Guerra, Isabel
AU  - Velez Garcia-Nieto, Antonio
AU  - Isla-Tejera, Beatriz
AU  - Ruano, Juan
PY  - 2019
DO  - 10.1136/bmjopen-2018-028303
UR  - http://hdl.handle.net/10668/14010
T2  - BMJ open
AB  - The Janus kinase and Signal Transducer and Activator of Transcription protein (JAK/STAT) pathway is known to be involved in inflammatory and neoplastic skin diseases, like psoriasis, atopic dermatitis, alopecia areata, vitiligo and melanoma. Improved...
LA  - en
PB  - BMJ Group
KW  - JAK/STAT pathway
KW  - PRISMA
KW  - Immune-mediated inflammatory skin diseases
KW  - Protocol
KW  - Scoping review
KW  - Humans
KW  - Janus Kinase Inhibitors
KW  - Janus Kinases
KW  - Nitriles
KW  - Piperidines
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Pyrroles
KW  - STAT Transcription Factors
KW  - Skin Diseases
TI  - Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review.
TY  - research article
VL  - 9
ER  -